Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1687-8329
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients ; volume:58 ; number:1 ; day:2 ; month:12 ; year:2022 ; pages:1-9 ; date:12.2022
The Egyptian journal of neurology, psychiatry and neurosurgery ; 58, Heft 1 (2.12.2022), 1-9, 12.2022

Creator
Shehata, Ghaydaa A.
Ahmed, Gellan K.
Hassan, Elham Ahmed
Rehim, Abeer Sharaf El-Din Abdel
Mahmoud, Saad Zaky
Masoud, Noha Ali
Seifeldein, Gehan S.
Hassan, Waleed Attia
Aboshaera, Khaled O.
Contributor
SpringerLink (Online service)

DOI
10.1186/s41983-022-00568-5
URN
urn:nbn:de:101:1-2023021321414334424382
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:58 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Shehata, Ghaydaa A.
  • Ahmed, Gellan K.
  • Hassan, Elham Ahmed
  • Rehim, Abeer Sharaf El-Din Abdel
  • Mahmoud, Saad Zaky
  • Masoud, Noha Ali
  • Seifeldein, Gehan S.
  • Hassan, Waleed Attia
  • Aboshaera, Khaled O.
  • SpringerLink (Online service)

Other Objects (12)

Direct-acting antivirals and visceral leishmaniasis: a case report

Direct-acting antivirals and visceral leishmaniasis: a case report

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications

Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway

Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway

Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals

Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals

Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis

Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis

Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals

Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals

Secular trends in cryoglobulinemia mortality in the USA in the era of direct-acting antivirals

Secular trends in cryoglobulinemia mortality in the USA in the era of direct-acting antivirals

Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study

Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study

Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals

Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals

Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection

Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection

Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity

Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity

A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals

A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals

Related objects